KE, S., JM, K., B, S., J, A., A, H., SW, H., . . . A, H. (2018). Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators. PloS one, 13(2), e0192717. https://doi.org/10.1371/journal.pone.0192717
Chicago Style (17th ed.) CitationKE, Schmidt, et al. "Doxycycline Inhibits Experimental Cerebral Malaria by Reducing Inflammatory Immune Reactions and Tissue-degrading Mediators." PloS One 13, no. 2 (2018): e0192717. https://doi.org/10.1371/journal.pone.0192717.
MLA (9th ed.) CitationKE, Schmidt, et al. "Doxycycline Inhibits Experimental Cerebral Malaria by Reducing Inflammatory Immune Reactions and Tissue-degrading Mediators." PloS One, vol. 13, no. 2, 2018, p. e0192717, https://doi.org/10.1371/journal.pone.0192717.